Live Breaking News & Updates on Olpruva|Page 2

Stay updated with breaking news from Olpruva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA Commercial Launch Progressing Ahead of Schedule

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA Commercial Launch Progressing Ahead of Schedule 01-May-2023 / 07:00 ....

Switzerland General , Chris Schelling , Catherine Day , Relief Therapeutics Holding Sa Key , Relief Therapeutics Holding , Therapeutics Inc , Drug Administration , Investor Relations Communications , News Service , University Of Washington , Acer Therapeutics Inc , Exchange Commission , Swiss Exchange , Launch Progressing Ahead , Relief Therapeutics , Medicare Part , Annual Meeting , Inherited Metabolic Disorders , Acer Therapeutics , Safety Information , Investor Relations , Relief Therapeutic ,

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA

Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA 15-March-2023 / 07:00 CET/CEST Release of an ad hoc announcement ....

Salt Lake City , United States , Switzerland General , Irina Koffler , Catherine Day , Dennis Riedl , Robert Steiner , Jack Weinstein , Relief Therapeutics Holding Sa Key , Data Presentation , Genetic Metabolic Dieticians International , Public Health , Therapeutics Inc , University Of Washington , Acer Therapeutics Inc , News Service , Ir Communications , Drug Administration , Pharma Research , University Of Wisconsin School Medicine , Swiss Exchange , Exchange Commission , Relief Therapeutics Holding , Acer Therapeutics , Annual Meeting , Inherited Metabolic Disorders ,

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA for Patients with Urea Cycle Disorders

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA for Patients with Urea Cycle Disorders 27-Dec-2022 ....

United States , Switzerland General , Irina Koffler , Catherine Day , Jim Denike , Chris Schelling , Tresa Warner , Nick Colangelo , Jack Weinstein , Ir Communications , Relief Therapeutics Holding Sa Key , Society For Inherited Metabolic Disorders , Genetic Metabolic Dieticians International , Drug Administration , National Urea Cycle Disorders Foundation , Swiss Exchange , Exchange Commission , University Of Washington , Gilmartin Group , Relief Therapeutics Holding , News Service , Acer Therapeutics Inc , Urea Cycle Disorders , Urea Cycle , National Urea Cycle Disorders , Federal Food ,